Filter
1720
Text search:
TB
incidence
Featured
177
522
Language
Document type
1071
251
190
67
44
42
26
17
5
2
2
1
Countries
81
66
58
54
51
50
48
38
38
37
35
33
32
32
30
29
28
27
26
26
25
24
22
21
20
20
15
14
13
12
12
12
12
11
10
10
9
9
8
7
7
7
6
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
835
129
68
39
32
14
13
Toolboxes
475
115
75
42
39
27
26
25
25
24
22
22
20
16
15
15
12
12
10
9
8
2
2
2
1
International Journal of Infectious Diseases 32 (2015) 111–117
Hindawi Publishing Corporation
Tuberculosis Research and Treatment
Volume 2015, Article ID 752709, 7 pages
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
Pathak et al. (2016), PeerJ, DOI 10.7717/peerj.1738; 1-14
Technical Brief
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
Rewiew Article
Hindawi Publishing Corporation, Tuberculosis Research and Treatment; Volume 2011, Article ID 712736, 6 pages, doi:10.1155/2011/712736
Eur Respir J. 2014 April ; 43(4): 1132–1141. doi:10.1183/09031936.00203613.
First report of a demonstration project
Tuberculosis profile Population 2018
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996